Core Viewpoint - The company is utilizing idle raised funds for cash management, with a total amount not exceeding 580 million RMB, ensuring the safety and liquidity of investments while maintaining the normal implementation of fundraising projects [2][9]. Summary by Sections Previous Cash Management - The company previously redeemed cash management products, recovering a total principal of 112 million RMB with respective earnings of 129,100 RMB, 292,600 RMB, and 616,400 RMB, and annualized returns of 2.17%, 1.20%, and 2.50% [4][3]. Current Cash Management Overview - The purpose of cash management is to enhance the efficiency of idle raised funds, with a current cash management amount of 20 million RMB [5][6]. - The source of funds for this cash management is from idle raised funds from a non-public offering in 2020 [7][8]. Cash Management Details - The company plans to invest 10 million RMB each in two structured deposits at Bohai Bank [9]. Approval Process - The cash management proposal was approved during the board and supervisory meetings held on April 25, 2025, and the annual shareholders' meeting on May 16, 2025 [9]. Financial Impact - As of June 30, 2025, the company's debt-to-asset ratio was 18.85%, indicating no significant debt while engaging in cash management [11]. - The cash management principal will be recorded as "trading financial assets" on the balance sheet, with earnings reflected in the profit statement as "investment income" [11]. Recent Cash Management Activities - The company has been actively managing raised funds over the past twelve months, indicating a strategic approach to utilizing idle resources [11].

Core Viewpoint - Hubei Jichuan Pharmaceutical Co., Ltd. is utilizing idle raised funds for cash management, specifically investing RMB 20 million in structured deposits with Bohai Bank, aiming to enhance fund efficiency while ensuring the safety of the raised funds [1][3]. Summary by Sections Cash Management Overview - The cash management involves an investment of RMB 20 million in two structured deposit products from Bohai Bank, each with a term of 181 days [1]. - The company has previously approved the use of up to RMB 580 million of idle raised funds for cash management, ensuring it does not affect the normal implementation of investment projects [1][5]. Previous Cash Management Activities - In previous cash management activities, the company redeemed a total of RMB 112 million from various cash management products, yielding returns of RMB 12.91 thousand, RMB 29.26 thousand, and RMB 61.64 thousand, with annualized returns of 2.17%, 1.20%, and 2.50% respectively [2][3]. Purpose and Compliance - The purpose of cash management is to improve the efficiency of idle raised funds while complying with regulatory requirements and ensuring that the funds are used safely and effectively [3][4]. - The company has established a three-party supervision agreement with the sponsor and the bank to ensure proper management of the raised funds [4]. Financial Impact - As of June 30, 2025, the company's asset-liability ratio stands at 18.85%, indicating a stable financial position without significant debt [6]. - The cash management principal will be recorded as "trading financial assets" on the balance sheet, with the income recognized in the profit statement as "investment income" [6][7]. Recent Cash Management Performance - In the last twelve months, the company has engaged in cash management activities with a total investment of RMB 45 million, achieving a cumulative return of 0.52% of the last year's net profit [7][8]. - The highest single-day investment in the past year was RMB 60 million, representing 4.08% of the last year's net assets [8].